Transient Ischemic Attack (TIA) market report is a comprehensive study of the ABC industry which tells about the market status in the forecast period of 2023-2030. This market analysis report also involves the drivers and restraints for the market that are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands that are driving the market are by systemic company profiles. The superior Transient Ischemic Attack (TIA) market research report displays comprehensive study on production capacity, consumption, import and export for all the major regions across the globe.
Transient ischemic attack (TIA) market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.60% in the above mentioned forecast period.
Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-transient-ischemic-attack-tia-market
Transient ischemic attack (TIA) is defined as a stroke that develops due to the blockage in blood flow to the brain. It occurs for short period of time as blood supply is restored quickly and prevents the death of brain tissue. It is caused due to blood clots that get trapped in the artery which supplies blood to the brain. It is characterised by tingling, dysphasia, weakness, dysarthria, confusion, vision changes, an altered level of consciousness, balance issues, headache, dizziness and an abnormal sense of taste and smell. This condition is also called mini stroke.
Global Transient Ischemic Attack (TIA) Market Scope and Market Size
The transient ischemic attack (TIA) market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the transient ischemic attack (TIA) market is segmented into anti-platelet drugs, anticoagulants, surgery, angioplasty and others. Anti-platelet drugs have been further sub-segmented into aspirin, prasugrel, clopidogrel and aspirin-dipyridamole. Anticoagulants have been further sub-segmented into rivaroxaban, warfarin and apixaban.
- On the basis of diagnosis, the transient ischemic attack (TIA) market is segmented into carotid ultrasonography, MRI, CT scan, echocardiography and others.
- On the basis of dosage, the transient ischemic attack (TIA) market is segmented into tablet, injection and others.
- On the basis of route of administration, the transient ischemic attack (TIA) market is segmented into oral, intravenous and others.
- On the basis of symptoms, the transient ischemic attack (TIA) market is segmented into tingling, dysphasia, weakness, dysarthria, confusion, vision changes, balance issues, headache, dizziness, an abnormal sense of taste and smell and others.
- On the basis of end-users, the transient ischemic attack (TIA) market is segmented into clinic, hospital and others.
The major players covered in the transient ischemic attack (TIA) market report are Abbott, Bayer AG, Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED., Boston Scientific Corp., electroCore, Inc., Cardinal Health, Cigna, Eli Lilly and Company, GENERAL ELECTRIC, LivaNova PLC, Medtronic, Merck KGaA, Novo Nordisk A/S, Siemens Healthcare GmbH, Stryker, Terumo Corporation, Zocere, Inc., Boehringer Ingelheim International GmbH., Johnson Johnson Private Limited, and Bristol-Myers Squibb Company, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
